Science Explorer Back to mapMap
Discussion
Company · Santa Clara · United States

Optivia Biotechnology (United States)

ROR OpenAlex
Research works
7
▲ 808% vs 2018-21
Citations
323
45.2 per fractional work
Top-10% rate
9.7%
all institutions 10.0%
Open access
66%
world 40%
International
23%
world 18%
Optivia Biotechnology (United States)

Not ranked overall: Optivia Biotechnology (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Optivia Biotechnology (United States) work in?

In all years, 53% of research at Optivia Biotechnology (United States) is in Health Sciences, 31% in Life Sciences. Its largest fields are Medicine (50%), Biochemistry, Genetics and Molecular Biology (27%), Physics and Astronomy (6%). It does 1.5× the world's share of Health Sciences.

Health Sciences: 4 fractional works · 53.3% of its workMedicine: 4 fractional works · 50.1% of its workOncology: 1 fractional works · 18.1% of its workOphthalmology: 1 fractional works · 9.4% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 7.0% of its workInfectious Diseases: 0 fractional works · 5.6% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 3.5% of its workHematology: 0 fractional works · 2.7% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 1.5% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 1.5% of its workPhysiology: 0 fractional works · 0.8% of its workNursing: 0 fractional works · 3.2% of its workNutrition and Dietetics: 0 fractional works · 3.2% of its workLife Sciences: 2 fractional works · 30.9% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 27.2% of its workMolecular Biology: 1 fractional works · 12.3% of its workBiochemistry: 1 fractional works · 8.6% of its workStructural Biology: 0 fractional works · 4.6% of its workMolecular Medicine: 0 fractional works · 1.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workImmunology and Microbiology: 0 fractional works · 2.5% of its workMicrobiology: 0 fractional works · 1.5% of its workVirology: 0 fractional works · 1.0% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 1.1% of its workPharmacology: 0 fractional works · 1.1% of its workPhysical Sciences: 1 fractional works · 15.8% of its workPhysics and Astronomy: 0 fractional works · 5.9% of its workCondensed Matter Physics: 0 fractional works · 4.6% of its workAtomic and Molecular Physics, and Optics: 0 fractional works · 1.1% of its workSmaller subfields together: 0 fractional works · 0.1% of its workChemistry: 0 fractional works · 4.6% of its workOrganic Chemistry: 0 fractional works · 4.6% of its workComputer Science: 0 fractional works · 1.8% of its workComputational Theory and Mathematics: 0 fractional works · 1.8% of its workEngineering: 0 fractional works · 1.4% of its workBiomedical Engineering: 0 fractional works · 0.8% of its workComputational Mechanics: 0 fractional works · 0.6% of its workEnvironmental Science: 0 fractional works · 1.0% of its workEcology: 0 fractional works · 1.0% of its workChemical Engineering: 0 fractional works · 0.6% of its workBioengineering: 0 fractional works · 0.6% of its workMaterials Science: 0 fractional works · 0.6% of its workMaterials Chemistry: 0 fractional works · 0.6% of its workALL ITS WORKOptiviaBiotechnology…7fractional works, all years
Life Sciences31%Physical Sciences16%Health Sciences53%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 12 fields, with their numbers
    1. Medicine450.1%
    2. Nursing03.2%
    1. Biochemistry, Genetics and Molecular Biology227.2%
    2. Immunology and Microbiology02.5%
    3. Pharmacology, Toxicology and Pharmaceutics01.1%
    1. Physics and Astronomy05.9%
    2. Chemistry04.6%
    3. Computer Science01.8%
    4. Engineering01.4%
    5. Environmental Science01.0%
    6. Chemical Engineering00.6%
    7. Materials Science00.6%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from Optivia Biotechnology (United States)?

The most cited paper from Optivia Biotechnology (United States) is "Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat" (Eve‐Irene Lepist, Xuexiang Zhang, Hao Jia et al., 2014), with 246 citations. Next come "Discovery of Potent, Selective Multidrug and Toxin Extrusion Transporter 1 (MATE1, SLC47A1) Inhibitors Through Prescription Drug Profiling and Computational Modeling" (144) and "Discovery of Competitive and Noncompetitive Ligands of the Organic Cation Transporter 1 (OCT1; SLC22A1)" (65).

Most cited papers
#PaperReleasedCitations
1 Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat Eve‐Irene Lepist, Xuexiang Zhang, Hao Jia et al. · Kidney International Open access 19 Mar 2014 246
2 Discovery of Potent, Selective Multidrug and Toxin Extrusion Transporter 1 (MATE1, SLC47A1) Inhibitors Through Prescription Drug Profiling and Computational Modeling Matthias Wittwer, Arik A. Zur, Natalia Khuri et al. · Journal of Medicinal Chemistry Open access 14 Dec 2012 144
3 Discovery of Competitive and Noncompetitive Ligands of the Organic Cation Transporter 1 (OCT1; SLC22A1) Eugene C. Chen, Natalia Khuri, Xiaomin Liang et al. · Journal of Medicinal Chemistry Open access 23 Feb 2017 65
4 Fluorescence-based assays for the assessment of drug interaction with the human transporters OATP1B1 and OATP1B3 Dallas Bednarczyk · Analytical Biochemistry Open access 11 Jun 2010 64
5 The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin Jennifer E. Hibma, Arik A. Zur, Richard A. Castro et al. · Clinical Pharmacokinetics Open access 23 Nov 2015 58
All 17 most cited papers, with filters and sorting

Which research topics does Optivia Biotechnology (United States) publish most on?

By volume in 2022-now: Physics of Superconductivity and Magnetism, Geomagnetism and Paleomagnetism Studies, Advanced Electron Microscopy Techniques and Applications and Cancer Immunotherapy and Biomarkers.

Physics of Superconducti…0Physics of Superconductivity and Magnetism: 0 fractional worksGeomagnetism and Paleoma…0Geomagnetism and Paleomagnetism Studies: 0 fractional worksAdvanced Electron Micros…0Advanced Electron Microscopy Techniques and Applications: 0 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional worksTelomeres, Telomerase, and Senescence: 0 fractional works
Condensed Matter PhysicsMolecular BiologyStructural BiologyOncology1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Physics of Superconductivity and Magnetism Condensed Matter Physics 0 works
  2. 2 Geomagnetism and Paleomagnetism Studies Molecular Biology 0 works
  3. 3 Advanced Electron Microscopy Techniques and Applications Structural Biology 0 works
  4. 4 Cancer Immunotherapy and Biomarkers Oncology 0 works
  5. 5 Telomeres, Telomerase, and Senescence Physiology 0 works
  6. 6 Nanoplatforms for cancer theranostics Biomedical Engineering 0 works
  7. 7 PARP inhibition in cancer therapy Oncology 0 works
  8. 8 Multiple Myeloma Research and Treatments Hematology 0 works
  9. 9 Cancer therapeutics and mechanisms Molecular Biology 0 works
  10. 10 DNA Repair Mechanisms Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available66.4%not open33.6%

World: 40% of research is openly available.

with international co-authors23.1%domestic only76.9%

World: 18% is written across borders.

How has Optivia Biotechnology (United States)'s research output changed?

Output in 2022-2025 was 808% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Optivia Biotechnology (United States) as a percentage of every work published that year, 0.0000026% in 2020.

still counting0.000020%0.000040%Optivia Biotechnology (United States)0.000020% in 20251990200020102020

Fractional works of Optivia Biotechnology (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Santa Clara

All research institutions in Santa Clara

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Optivia Biotechnology (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.